Rafael Pharmaceuticals, Inc.
Records under this name other than the patents Rafael Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 7 of 7 · Back to Rafael Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,691,873 | Pharmaceutical formulations containing lipoic acid derivatives Lapsed on the fee record Ended Apr 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | From the USPTO record |
| US 9,872,845 | Methods of treating myeloma and lymphoma using compositions containing an ion pair of a lipoic acid derivative Formerly held Lapsed on the fee record Ended Jan 23, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 23, 2026 | From the USPTO record |
| US 9,839,691 | Methods of treating pancreatic and ovarian cancers using compositions containing an ion pair of a lipoic acid derivative Lapsed on the fee record Ended Dec 12, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 12, 2025 | From the USPTO record |
| US 11,065,335 | Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereof Lapsed on the fee record Ended Jul 20, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 20, 2025 | From the USPTO record |
| US 9,320,726 | Methods of treating colon, lung, and liver cancers using compositions containing an ion pair of a lipoic acid derivative Lapsed on the fee record Ended Apr 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2024 | From the USPTO record |
| US 10,526,357 | Pharmaceutical compounds Lapsed on the fee record Ended Jan 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2024 | From the USPTO record |
| US 10,450,337 | Pharmaceutical compounds Lapsed on the fee record Ended Oct 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2023 | From the USPTO record |